Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

NCT05260073 · clinicaltrials.gov ↗

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratosis, Actinic

Interventions

DRUG: Tirbanibulin

Sponsor

Almirall, S.A.